Results 101 to 110 of about 93,891 (304)

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

cfDNA methylation detection as potential liquid biopsy of multiple organ injury in myocarditis patients

Clinical Epigenetics
Myocarditis is inflammatory injury of the myocardium and causes approximately 30,000 deaths globally each year. Fulminant myocarditis is an extremely severe form of myocarditis.
Yangchao Zhao, Yujia Wang, Xi Zhao, Xin Zhang, Haoyan Wang, Liang Cui, Huifen Wang, Weiwei Zhu, Boyan Li, Yanjun Zhou, Jun Li, Guowei Fu, Yiheng Zhou, Pengwei Sun, Jing Bai, Xuefeng Xia, Xin Yi, Ling Yang, Chaoqun Chen, Junnan Tang, Ang Li, Zujiang Yu   +21 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

villani-lab/myocarditis: Publication code release

<p>Code for publication "Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor"</p ...
nealpsmith, ikernin, swemeshy
core   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Myocarditis in Humans and in Experimental Animal Models

Frontiers in Cardiovascular Medicine, 2019
Myocarditis is defined as an inflammation of the cardiac muscle. In humans, various infectious and non-infectious triggers induce myocarditis with a broad spectrum of histological presentations and clinical symptoms of the disease.
Przemysław Błyszczuk, Przemysław Błyszczuk   +1 more
doaj   +1 more source

Forensic grading of myocarditis : an experimental contribution to the distinction between lethal myocarditis and incidental myocarditis

, 2012
Myocarditis can be either the cause of the death of a person or just an incidental finding during the autopsy and the following histological examinations.
A. Lazzaro, M.B. Casali, A. Blandino, E. Ronchi, R. Zoja, G. Gentile   +5 more
core   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Investigating pathological features of myocarditis-related sudden cardiac deaths in Egypt

Egyptian Journal of Forensic Sciences
Background Myocarditis is an inflammatory condition of the myocardium. A definitive diagnosis requires histopathological examination. The scarcity of autopsy data has led to this study, which analyzed the histopathological features of myocarditis-related
Nora Fnon, Asmaa Sharif, Hanan Hassan, Amal Hafez, Zahraa Sobh   +4 more
doaj   +1 more source

Ventricular myocarditis coincides with atrial myocarditis in patients

, 2016
Introduction: Atrial fibrillation (AF) is a common complication in myocarditis. Atrial inflammation has been suggested to play an important role in the pathophysiology of AF.
Heymans, Stephane, Paulus, Walter J., Rozendaal, Lawrence, Niessen, Hans W. M., van Rossum, Albert C., Rijvers, Liza, Krijnen, Paul A. J., Vonk, Alexander B. A., Begieneman, Mark P. V., Kubat, Bela, Wouters, Diana, Zeerleder, Sacha, Emmens, Reindert W., Biesbroek, P. Stefan, van Ham, Marieke   +14 more
core   +1 more source